跳至主要内容
临床试验/JPRN-UMIN000026465
JPRN-UMIN000026465招募中未知

Comparison between tenofovir alafenamide and entecavir in the efficacy and safety for chronic hepatitis B patients treatment. - Comparison between tenofovir alafenamide and entecavir in the efficacy and safety for chronic hepatitis B patients treatment.

Kindai University Faculty of Medicine0 个研究点目标入组 60 人开始时间: 2017年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 100years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with the past history of hypersensitivity against biologicals such as vaccine. Patients using Sho-saiko-to at present Autoimmune disease patients Patients with the past history of hypersensitivity against TAF and/or Entecavir

研究者

相似试验